Purpose/Objective: Limited clinical data with respect to peripheral doses is available, demonstrating differences between VMAT and IMRT. The aim of this work was to measure the low dose distribution in peripheral regions (thyroid, lung, stomach, gonads) for prostate, lung and rectum plans in a phantom and compare the results between IMRT and VMAT. Materials and Methods: In this study 28 plans were selected at Institut Jules Bordet : 11 prostate plans, 8 rectum plans and 9 lung plans originated from previously treated patients. The total doses delivered were 45-66 Gy, using different fractionation schemes for each pathology. They were both computed for VMAT and IMRT modalities. All the measurements were performed with an Elekta Infinity TM + Agility TM Head (6MV). Alderson Phantom provided the human like medium for the irradiation. For the group of prostate and rectum plans, we used 4 TLDs for each treatment plan. They were placed at specific points, close to sensitive organs, having a higher probability of radiation induced effects: thyroid, lung (thorax), stomach and gonads. For lung plans, 3 TLDs were placed at the thyroid, stomach and gonads. Results: VMAT showed lower absorbed doses for peripheral organs farther from the isocenter field, while IMRT presented a decrease in absorbed doses in peripheral organs closer to the irradiation field. VMAT technique increases the scattering from the patient due to the full rotation gantry with beam on. Then the peripheral organs closer to the irradiation field have an increase in absorbed dose. IMRT treatment increases the leakage radiation from the machine, which contributes with dose at distance and then the increase of absorbed dose for organs farther from the irradiation field. Conclusions: To our knowledge this study is the most informative in terms of number of samples. The results show that the scattered dose is very important close to the in-field region. As the distance from isocenter increases, the leakage dose becomes predominant. This aspect is also relevant when using the cancer risk model. This is important for young patients or children, who are still in a very active cell proliferation phase of their lives and have time to develop other cancers in the future. Future works should be performed to evaluate the most common radio-induced cancers related for each pathology. That would allow physicists and physicians to decide which modality of treatment to choose with a decreased risk for young patients. Purpose/Objective: Small field dosimetry constitutes a critical issue in modern radiotherapy. Various detectors had been designed to analyse fields up to 4x4 cm 2 : among these Exradin A26 Ion chamber (Standard Imaging), recently commercialized. The aim of this work is to characterize this ionization chamber (IC) for small field dosimetry. Materials and Methods: A26 IC (collecting volume 0.015 cc, typical of microchambers), was irradiated with a 6 MV photon beam provided by a Elekta Synergy Linac. All measurements were performed in water. The signal was collected by PC Electrometer (Sun Nuclear). Short term stability, dose linearity and dependence on dose rate had been tested for 10x10 and 4x4 cm 2 fields. The behaviour of Ppol and Pion correction factors had been examined varying the field sizes from 1x1 cm 2 to 10x10 cm 2 . Output factors (OF) were acquired for fields ranging between 1x1 cm 2 and 25x25 cm 2 . Field profiles and Percentage Depth Dose (PDD) measurements were performed for 1x1, 2x2 and 3x3 cm 2 fields. OF comparison had been executed with a diode detector (EDGE diode, Sun Nuclear); profiles and PDD were compared with measurements obtained by A1SL IC (Standard Imaging, collecting volume 0.053 cc) and diode. Results: A26 short term measurements showed good stability (standard deviations lower than 0.2%) for both 10x10 and 4x4 cm 2 fields. Dose linearity had been verified (r 2 ≈ 1); dose rate readings from 37 to 700 MU/min showed a 3% and 4% maximum variation for 10x10 and 4x4 cm 2 fields respectively, at low dose rates. Ppol maximum variation, for fields up to 10x10 cm 2 , was 0.8% while Pion showed a 0.4% maximum difference for the examined fields. The comparison between OF acquired with A26 and diode showed a mean difference of 0.7%; an exception is given by 1x1 cm 2 field, in which a 7.7% discrepancy between detectors was noticed. Profiles scanned by A26 were in agreement with diode (0.5 mm maximum penumbra variation for 2x2 cm 2 field). The comparison with profiles acquired by A1SL showed a 0.2 mm maximum penumbra difference for 3x3 cm 2 field. A26 Full Width at Half Maximum (FWHM) measurements showed a 0.4 mm (for 3x3 cm 2 field) and 0.2 mm (for 1x1 and 2x2 cm 2 fields) maximum difference compared to the results obtained by diode and A1SL respectively. As regards PDD, a good agreement was achieved between A26 and both diode and A1SL readings for 2x2 and 3x3 cm 2 fields (maximum difference 1.7%); for 1x1 cm 2 field (as shown in figure) , as depth increased, a not negligible difference (up to 10%) was observed between A26 and A1SL while the comparison with diode confirmed the good accordance shown previously.
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Conclusions: Not negligible differences between detectors were observed. Montecarlo correction factors for diode might explain the OF discrepancy with A26, while the A1SL bigger collecting volume could justify the variation observed in 1x1 cm 2 field PDD. Due to the lack of a gold standard detector for small field dosimetry, the previous measurements showed the reliability of A26 as detector for small fields. Purpose/Objective: Contemporary radiotherapy approaches widely employ 'non standard' photon beams raising unprecedented challenges for absolute dose determination. In particular, standard reference dosimetry for small fields used in stereotactic radiosurgery treatments is substantially unfeasible. The implementation of new technologies for dosimetry is mandatory. The aim of this work is to characterize Exradin W1, a plastic scintillation detector manufactured by Standard Imaging, Inc. that seems to be promising in term of water equivalence, spatial resolution, dose rate and energy dependence for small field dosimetry purpose. Materials and Methods: Exradin W1 was irradiated in vertical position (axis parallel to beam axis) in a water phantom with 6MV and 10 MV photon beams produced by a Varian Accelerator. Beam stability during irradiation was monitored with a PTW Semiflex Ionization Chamber (IC). W1 dose calibration for both energies was carried on at 10 cm depth in a 10x10cm 2 field, in two different condition of irradiated optical fiber length. Dose linearity was investigated at a dose rate of 300MU/min ranging from 4 to 1000 MU in 10x10 cm 2 field. Dose-rate dependence was also studied varying from 100 to 600 MU/min. The detector response depending on gantry orientation was tested in a 5x5cm 2 field, at 10° step angles from 340°to 40°. Relative output factors (ROF) were measured at 10cm depth for both energies with W1, PTW PinPoint IC and PTW microdiamond detector up to 0.4x.04cm 2 field. Results were also compared with Pinnacle 3 and RayStation TPSs calculated values. Results: Detector dose response showed a optimal linearity both for 6MV and 10MV, less than 0.5% up to 4MU and 1% for MU<4 but due to accelerator behavior. Regarding dose-rate dependence a standard deviation of 0.3% was observed among measurements performed in the range all dose-rates tested. Detector response showed a not negligible dependence on the length of fiber irradiated, observed both in calibration setup and during measurements at different gantry angle. Output factor measured with the 3 detectors showed a maximum difference of 1% for the 1x1cm 2 field. A poorer agreement was found for smaller field dimension. As expected, the same trend was observed comparing W1 detector measured ROF with calculated values, that is, a difference less than 0.5% up to 1x1cm 2 and worse beyond. Conclusions: Exradin W1 is a new detector that seems to introduce a minimum perturbation of the beam fluence. It is fast in data collection and easy to set up and manage. It show a good behavior in term of dose linearity and dose rate independence. MV is also reported to be dose-rate independent up to ultrahigh (≥ 10 6 Gy/s) dose-rates. The recent interest into using MV as a clinical dosimeter in radiotherapy is coupled with promising new radiotherapy techniques operating at these dose-rates, e.g. Flash irradiation and synchrotron radiation therapy. The purpose of this study is to characterize MV as a clinical dosimeter and to reveal its potential use in routine measurements at a radiotherapy department. Materials and Methods: When ionizing radiation interacts with a MV solution it produces radicals, which display a characteristic blue color. This occurs as visible light is strongly absorbed, with absorbance peaks at wavelengths (λ) of around 395 nm and 603 nm. Consequently, the absorbed dose by a MV solution is readily determined by measuring the optical density (absorbance) at those particular wavelengths
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